These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 20217586)
1. Molecular-targeted therapy for cancer and nanotechnology. Hochwald SN Methods Mol Biol; 2010; 624():11-23. PubMed ID: 20217586 [TBL] [Abstract][Full Text] [Related]
2. Colloidal gold: a novel nanoparticle for targeted cancer therapeutics. Powell AC; Paciotti GF; Libutti SK Methods Mol Biol; 2010; 624():375-84. PubMed ID: 20217609 [TBL] [Abstract][Full Text] [Related]
3. Emerging nanomedicines for early cancer detection and improved treatment: current perspective and future promise. Bharali DJ; Mousa SA Pharmacol Ther; 2010 Nov; 128(2):324-35. PubMed ID: 20705093 [TBL] [Abstract][Full Text] [Related]
4. Review: nanoparticles in drug delivery for the treatment of cancer. Arayne MS; Sultana N Pak J Pharm Sci; 2006 Jul; 19(3):258-68. PubMed ID: 16935836 [TBL] [Abstract][Full Text] [Related]
5. Use of nanoparticles for targeted, noninvasive thermal destruction of malignant cells. Cherukuri P; Curley SA Methods Mol Biol; 2010; 624():359-73. PubMed ID: 20217608 [TBL] [Abstract][Full Text] [Related]
6. Application of nanotechnology in biomedicine. Navalakhe RM; Nandedkar TD Indian J Exp Biol; 2007 Feb; 45(2):160-5. PubMed ID: 17375555 [TBL] [Abstract][Full Text] [Related]
8. Multifunctional magneto-polymeric nanohybrids for targeted detection and synergistic therapeutic effects on breast cancer. Yang J; Lee CH; Ko HJ; Suh JS; Yoon HG; Lee K; Huh YM; Haam S Angew Chem Int Ed Engl; 2007; 46(46):8836-9. PubMed ID: 17943947 [No Abstract] [Full Text] [Related]
9. Pathogenesis of metastatic disease: implications for current therapy and for the development of new therapeutic strategies. Poste G Cancer Treat Rep; 1986 Jan; 70(1):183-99. PubMed ID: 3510734 [TBL] [Abstract][Full Text] [Related]
10. Anticancer drug delivery with nanoparticles. Conti M; Tazzari V; Baccini C; Pertici G; Serino LP; De Giorgi U In Vivo; 2006; 20(6A):697-701. PubMed ID: 17203748 [TBL] [Abstract][Full Text] [Related]
11. Designer adenoviruses for nanomedicine and nanodiagnostics. Singh R; Kostarelos K Trends Biotechnol; 2009 Apr; 27(4):220-9. PubMed ID: 19251331 [TBL] [Abstract][Full Text] [Related]
12. Biodegradable, polymeric nanoparticle delivery systems for cancer therapy. Pridgen EM; Langer R; Farokhzad OC Nanomedicine (Lond); 2007 Oct; 2(5):669-80. PubMed ID: 17976029 [TBL] [Abstract][Full Text] [Related]
17. LHRH-targeted nanoparticles for cancer therapeutics. Minko T; Patil ML; Zhang M; Khandare JJ; Saad M; Chandna P; Taratula O Methods Mol Biol; 2010; 624():281-94. PubMed ID: 20217603 [TBL] [Abstract][Full Text] [Related]
18. Applications for site-directed molecular imaging agents coupled with drug delivery potential. Wang H; Chen X Expert Opin Drug Deliv; 2009 Jul; 6(7):745-68. PubMed ID: 19552614 [TBL] [Abstract][Full Text] [Related]
19. Composite nanoparticles take aim at cancer. Gil PR; Parak WJ ACS Nano; 2008 Nov; 2(11):2200-5. PubMed ID: 19206383 [TBL] [Abstract][Full Text] [Related]
20. Nanoparticle therapeutics for prostate cancer treatment. Sanna V; Sechi M Nanomedicine; 2012 Sep; 8 Suppl 1():S31-6. PubMed ID: 22640911 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]